Surgery Partners, Inc.
US ˙ NasdaqGS ˙ US86881A1007

Introduction

This page provides a comprehensive analysis of the known insider trading history of David T Doherty. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David T Doherty has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SGRY / Surgery Partners, Inc. Chief Financial Officer 103,377
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David T Doherty. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SGRY / Surgery Partners, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SGRY / Surgery Partners, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Sales SGRY / Surgery Partners, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SGRY / Surgery Partners, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-08 SGRY Doherty David T 47,491 23.3900 47,491 23.3900 1,110,814 27 22.3600 -48,915 -4.40
2025-03-10 SGRY Doherty David T 6,733 24.0200 6,733 24.0200 161,727
2025-02-07 SGRY Doherty David T 13,641 25.6100 13,641 25.6100 349,346
2024-03-14 SGRY Doherty David T 721 28.5900 721 28.5900 20,613
2024-03-04 SGRY Doherty David T 3,426 30.3700 3,426 30.3700 104,048
2024-02-12 SGRY Doherty David T 1,020 34.9300 1,020 34.9300 35,629
2024-02-02 SGRY Doherty David T 2,306 31.8900 2,306 31.8900 73,538
2023-08-30 SGRY Doherty David T 2,000 36.1210 2,000 36.1210 72,242
2023-08-29 SGRY Doherty David T 202 35.2110 202 35.2110 7,113
2023-03-15 SGRY Doherty David T 21 30.1100 21 30.1100 632
2023-03-14 SGRY Doherty David T 2,669 31.1100 2,669 31.1100 83,033
2023-03-13 SGRY Doherty David T 682 29.8600 682 29.8600 20,365
2023-03-03 SGRY Doherty David T 20,000 33.9800 20,000 33.9800 679,600
2023-02-27 SGRY Doherty David T 4,315 33.5300 4,315 33.5300 144,682
2023-02-13 SGRY Doherty David T 942 33.9200 942 33.9200 31,953
2023-02-02 SGRY Doherty David T 1,947 35.9000 1,947 35.9000 69,897
2022-08-30 SGRY Doherty David T 171 29.6500 171 29.6500 5,070
2022-03-16 SGRY Doherty David T 1,091 50.9000 1,091 50.9000 55,532
2022-03-15 SGRY Doherty David T 3,678 49.2900 3,678 49.2900 181,289
2022-03-11 SGRY Doherty David T 376 54.6900 376 54.6900 20,563
2022-02-25 SGRY Doherty David T 2,221 50.4800 2,221 50.4800 112,116

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SGRY / Surgery Partners, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David T Doherty as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-08 2025-08-08 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -47,491 103,377 -31.48 23.39 -1,110,814 2,417,988
2025-03-13 2025-03-10 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -6,733 150,868 -4.27 24.02 -161,727 3,623,849
2025-03-06 2025-03-04 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 15,126 157,601 10.62 23.80 359,999 3,750,904
2025-03-06 2025-03-04 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 33,613 142,475 30.88 23.80 799,989 3,390,905
2025-02-10 2025-02-07 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -13,641 108,862 -11.14 25.61 -349,346 2,787,956
2025-02-04 2025-01-31 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 26,784 122,503 27.98
2024-03-15 2024-03-14 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -721 95,719 -0.75 28.59 -20,613 2,736,606
2024-03-06 2024-03-04 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -3,426 96,440 -3.43 30.37 -104,048 2,928,883
2024-03-01 2024-02-28 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 25,657 99,866 34.57 31.18 799,985 3,113,822
2024-02-14 2024-02-12 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -1,020 74,209 -1.36 34.93 -35,629 2,592,120
2024-02-06 2024-02-02 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -2,306 75,229 -2.97 31.89 -73,538 2,399,053
2023-09-01 2023-08-30 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -2,000 77,535 -2.51 36.12 -72,242 2,800,642
2023-09-01 2023-08-29 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -202 79,535 -0.25 35.21 -7,113 2,800,507
2023-03-15 2023-03-15 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -21 79,737 -0.03 30.11 -632 2,400,881
2023-03-15 2023-03-14 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -2,669 79,758 -3.24 31.11 -83,033 2,481,271
2023-03-15 2023-03-13 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -682 82,427 -0.82 29.86 -20,365 2,461,270
2023-03-06 2023-03-03 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -20,000 83,109 -19.40 33.98 -679,600 2,824,044
2023-03-06 2023-03-02 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 30,432 103,109 41.87 32.86 999,996 3,388,162
2023-03-06 2023-03-02 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 21,302 72,677 41.46 32.86 699,984 2,388,166
2023-03-01 2023-02-27 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -4,315 51,375 -7.75 33.53 -144,682 1,722,604
2023-02-15 2023-02-13 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -942 55,690 -1.66 33.92 -31,953 1,889,005
2023-02-06 2023-02-02 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -1,947 56,632 -3.32 35.90 -69,897 2,033,089
2022-08-31 2022-08-30 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -171 58,579 -0.29 29.65 -5,070 1,736,867
2022-03-17 2022-03-16 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -1,091 58,750 -1.82 50.90 -55,532 2,990,375
2022-03-17 2022-03-15 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -3,678 59,841 -5.79 49.29 -181,289 2,949,563
2022-03-14 2022-03-11 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -376 63,519 -0.59 54.69 -20,563 3,473,854
2022-03-02 2022-02-25 4 SGRY Surgery Partners, Inc.
Common Stock
S - Sale -2,221 59,435 -3.60 50.48 -112,116 3,000,279
2022-03-02 2022-02-10 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 4,460 63,895 7.50 42.04 187,498 2,686,146
2022-02-03 3 SGRY Surgery Partners, Inc.
Common Stock
48,264
2022-02-03 2022-02-01 4 SGRY Surgery Partners, Inc.
Common Stock
A - Award 13,392 61,656 27.75 44.80 599,962 2,762,189
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)